Nutra Pharma Corp (NPHC) Other Accumulated Expenses (2018 - 2026)

Nutra Pharma has disclosed Other Accumulated Expenses across 9 years of filings, most recently posting $1.8 million for Q2 2026.

• In Q2 2026, Other Accumulated Expenses rose 28.09% year-over-year to $1.8 million; the TTM figure through Jun 2026 stood at $1.8 million (up 28.09% YoY), while the FY2025 annual figure was $1.6 million, up 28.53% from the prior year.
• Other Accumulated Expenses came in at $1.8 million for Q2 2026 at Nutra Pharma, up from $1.7 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.8 million in Q2 2026 to a low of $2445.0 in Q2 2022.
• Average Other Accumulated Expenses over 5 years is $883475.6, with a median of $1.1 million recorded in 2024.
• Year-over-year, Other Accumulated Expenses sank 70.29% in 2022 and soared 19797.36% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $112046.0 in 2022, then surged by 488.54% to $659433.0 in 2023, then surged by 87.93% to $1.2 million in 2024, then grew by 28.53% to $1.6 million in 2025, then rose by 11.37% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.8 million in Q2 2026, $1.7 million in Q1 2026, and $1.6 million in Q4 2025.